Skip to content

Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography

Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01803386
Enrollment
20
Registered
2013-03-04
Start date
2013-01-31
Completion date
2015-03-31
Last updated
2015-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Keywords

ALS, EIM

Brief summary

The purpose of this protocol is to test a new Electrical Impedance Myography (EIM) device and study its reliability and ability to differentiate ALS patients from healthy controls.

Detailed description

Investigators will study 10 ALS patients and at least 10 age-matched healthy controls between the ages of 21 and 85 years old. For all subjects, EIM measurements will be performed on four muscles: two in the upper and two in the lower extremities, using 8 different EIM sensors. Measurements will be repeated one time.

Interventions

EIM measurements are taken by applying saline to the skin and placing a sensor on patients' muscles that will record electrical activity. Electrical current is generated by this machine, but patients will not be able to feel it. The electrical activity recorded is returned to the machine and analyzed by a computer.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Skulpt, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of probable or definite ALS by the El Escorial Criteria

Exclusion criteria

* History of superimposed generalized neuromuscular disease * Primary lateral sclerosis or other atypical motor neuron disorders * Forced vital capacity of less than 50% * Presence of disease for greater than 5 years since symptom onset

Design outcomes

Primary

MeasureTime frameDescription
Muscle health as captured by EIM measurementsOne time visit - Day 1EIM measurements will be performed with several electrode arrays at one visit per patient. The data captured from ALS and healthy subjects will be used to refine and finalize electrode array design development for the EIM system.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026